| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |